Skip to main content

Table 3 Criteria for inactive disease and clinical remission in juvenile idiopathic arthritisa

From: Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis

   No active synovitis
   No fever, rash, serositis, splenomegaly, or generalized lymphadenopathy attributable to juvenile idiopathic arthritis
   No active uveitis
   Normal erythrocyte sedimentation rate and/or C-reactive protein
   Physician's global assessment of disease activity indicates no active disease
Inactive disease
   Requires that the patient satisfy all of the above criteria
Clinical remission on medication
   Six continuous months of inactive disease on medication
Clinical remission off of medication
   12 continuous months of inactive disease off all anti-arthritis and anti-uveitis medications
  1. aApplies to oligoarticular, polyarticular (rheumatoid factor-negative, rheumatoid factor-positive) and systemic juvenile idiopathic arthritis at this time.
  2. Table reproduced with permission from Ringold S, Wallace CA: Measuring clinical response and remission in juvenile idiopathic arthritis. Curr Opin Rheumatol 2007, 19:471–476 [9]. Data from Wallace and collegues [52].